JOOTRH strengthens cancer care partnership with Washington University in Kenya

The partnership builds on a Memorandum of Collaboration signed last year under the Global Oncology Initiative, which set the foundation for comprehensive cancer management improvements at the regional referral facility.

KENYA—Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) has enhanced its collaboration with Washington University (WashU) through renewed partnerships to improve cancer care, research capabilities, and medical workforce training across Western Kenya.

The partnership builds on a Memorandum of Collaboration signed last year under the Global Oncology Initiative, which set the foundation for comprehensive cancer management improvements at the regional referral facility.

 The next phase of implementation

A delegation from Washington University, led by Dr. Thomas Odeny and Betsy Abente, recently held strategic discussions with JOOTRH’s oncology team and hospital leadership.

The meetings reviewed progress made since the partnership’s inception and outlined critical priorities for the next implementation phase.

The collaboration focuses on establishing data-driven cancer management systems, enhancing workforce training programs, developing robust research frameworks, and strengthening patient support mechanisms throughout the treatment continuum.

Clinical dashboard reveals cancer patterns and treatment gaps

One of the partnership’s key achievements is the development of a clinical cancer dashboard, created through joint efforts between JOOTRH and Washington University teams.

The dashboard actively tracks cancer trends, patient outcomes, and service-delivery gaps, providing hospital leadership with actionable insights to improve care.

Data from the system shows that cervical cancer remains the most common diagnosis at JOOTRH, followed by oesophageal, breast, prostate, and colorectal cancers.

The findings reveal a concerning pattern: most patients arrive at the hospital with advanced-stage disease, which significantly limits available treatment options and reduces survival outcomes.

Patient retention and financing challenges demand urgent solutions

The dashboard has also exposed critical gaps in patient continuity and healthcare financing.

Approximately 44 percent of oncology patients are lost to follow-up, meaning they fail to complete their treatment courses or attend scheduled appointments.

Nearly a quarter of patients pay cash for their cancer treatment, highlighting significant financial barriers that prevent many from accessing consistent care.

These challenges complicate efforts to deliver effective long-term cancer management and point to systemic issues requiring immediate intervention.

Digital systems and community outreach strengthen patient tracking

In response to these findings, JOOTRH is implementing digital tracking solutions through Kenya’s national health information systems, specifically leveraging the Afya-ke platform to improve patient monitoring.

The hospital is also expanding its Mashinani outreach initiative, which supports community-based cancer screening programs and facilitates the tracing of patients who have missed appointments.

These efforts aim to bridge the gap between diagnosis and treatment completion while addressing the geographical and financial barriers that prevent patients from accessing continuous care.

Multidisciplinary training and research collaboration

The partnership extends beyond clinical care to include comprehensive capacity-building initiatives.

Washington University supports multidisciplinary training programs, leadership development courses, grant-writing skills workshops, and implementation science projects at JOOTRH.

Several joint research projects are currently underway, including cancer epidemiology studies examining disease patterns in the region, patient retention models under the Harambee and Pamoja frameworks, and diagnostic innovation projects aimed at improving early detection rates.

Both institutions are also exploring pathways to establish clinical trials at JOOTRH, which would provide patients access to cutting-edge treatments while contributing valuable data to global cancer research.

JOOTRH Chief Executive Officer Dr. Joshua Clinton Okise emphasized that robust data systems and international partnerships play an essential role in guiding priority setting, improving treatment planning, and shaping evidence-based cancer care policies at the facility.

  

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Newer Post

Thumbnail for JOOTRH strengthens cancer care partnership with Washington University in Kenya

West Africa launches innovative roadmap to ensure equitable access to Lassa fever vaccines

Older Post

Thumbnail for JOOTRH strengthens cancer care partnership with Washington University in Kenya

SanegeneBio signs USD1.5B licensing agreement with Genentech for its RNAi therapy platform

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *